1964
DOI: 10.1001/archotol.79.6.613
|View full text |Cite
|
Sign up to set email alerts
|

Upper Respiratory Tract Plasmacytoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
14
0

Year Published

1967
1967
2013
2013

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(14 citation statements)
references
References 0 publications
0
14
0
Order By: Relevance
“…All 67 studies included individual patient data that was extractable and fit the minimum criteria for inclusion. The 67 studies are detailed in Table …”
Section: Resultsmentioning
confidence: 99%
“…All 67 studies included individual patient data that was extractable and fit the minimum criteria for inclusion. The 67 studies are detailed in Table …”
Section: Resultsmentioning
confidence: 99%
“…Dissemination eventually occurs in 35-50% of patients with primary EMP to MM over a period of months to years, at times as late as several decades after diagnosis. 13,14 Treatment for MM is multidrug chemotherapy.…”
Section: Discussionmentioning
confidence: 99%
“…Plasmacytic, plasmablastic and anaplastic subtypes have been described, but histological appearance is not a reliable indicator of biological activity. 1 Local amyloid deposits have been found in 11-38 per cent of cases but systemic amyloidosis is very rare.…”
Section: Discussionmentioning
confidence: 99%
“…They may remain localized or become disseminated. 1 Patients with plasmacytoma require long-term follow-up to detect possible conversion to multiple myeloma. 2…”
Section: Introductionmentioning
confidence: 99%